Deutsche Bank AG Takes Position in MetLife, Inc. $MET

Deutsche Bank AG purchased a new position in shares of MetLife, Inc. (NYSE:MET - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 2,602,601 shares of the financial services provider's stock, valued at approximately $220,206,000. Deutsche Bank AG owned about 0.40% of MetLife at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Activest Wealth Management boosted its stake in MetLife by 205.8% in the fourth quarter. Activest Wealth Management now owns 315 shares of the financial services provider's stock worth $25,000 after purchasing an additional 212 shares in the last quarter. Garton & Associates Financial Advisors LLC acquired a new stake in shares of MetLife in the fourth quarter valued at $30,000. Gunpowder Capital Management LLC dba Oliver Wealth Management acquired a new stake in shares of MetLife in the fourth quarter valued at $31,000. Prosperity Bancshares Inc bought a new position in shares of MetLife in the fourth quarter valued at about $31,000. Finally, JPL Wealth Management LLC bought a new position in shares of MetLife in the third quarter valued at about $33,000. 94.99% of the stock is owned by institutional investors and hedge funds.

More MetLife News

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: DOWLING & PARTN raised its fiscal 2027 earnings estimate for MetLife to $10.85 per share from $10.75. The revision suggests improving analyst expectations for the insurer’s future profitability and is favorable for MET, although the new estimate remains above the broader current-year consensus of $9.70. MetLife FY2027 earnings estimate
• Neutral Sentiment: MetLife declared third-quarter 2026 dividends on several series of preferred stock, including Series A, Series D, Series E and Series F. The payments reinforce the company’s ongoing capital-return commitments, but they primarily affect preferred shareholders and are unlikely to materially change the valuation of MET common shares. MetLife preferred stock dividends
• Neutral Sentiment: MetLife published its 2025 sustainability report, highlighting research and insights related to its environmental, social and governance initiatives. The report may support the company’s long-term reputation with stakeholders, but it is not expected to have an immediate earnings impact. MetLife 2025 sustainability report
• Neutral Sentiment: Several headlines concern MetLife Stadium, including a new stadium CEO, rapid transitions between Jets and Giants games, and upcoming concerts. These stories relate to the sports and entertainment venue—not MetLife, Inc.’s insurance and financial-services operations—and should not materially affect MET stock. MetLife Stadium names new CEO

Analyst Ratings Changes

A number of equities research analysts have commented on MET shares. Atlantic Securities set a $103.00 price objective on shares of MetLife in a report on Wednesday, July 15th. Mizuho boosted their target price on shares of MetLife from $95.00 to $102.00 and gave the stock an "outperform" rating in a research note on Thursday, July 9th. Weiss Ratings upgraded shares of MetLife from a "buy (b-)" rating to a "buy (b)" rating in a research report on Monday, June 15th. Barclays increased their price target on shares of MetLife from $94.00 to $97.00 and gave the company an "overweight" rating in a research note on Thursday, August 6th. Finally, Jefferies Financial Group raised their price target on shares of MetLife from $97.00 to $103.00 and gave the company a "buy" rating in a report on Friday, July 10th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, MetLife presently has a consensus rating of "Moderate Buy" and a consensus price target of $101.07.

MetLife Stock Performance

Shares of NYSE:MET opened at $96.83 on Wednesday. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.52. MetLife, Inc. has a 1-year low of $67.33 and a 1-year high of $100.93. The stock has a market capitalization of $62.31 billion, a P/E ratio of 18.55, a P/E/G ratio of 0.75 and a beta of 0.78. The business has a 50-day moving average price of $92.00 and a two-hundred day moving average price of $81.86.

MetLife (NYSE:MET - Get Free Report) last issued its earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The company had revenue of $13.52 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter last year, the firm earned $2.02 EPS. The company's revenue for the quarter was up 10.5% on a year-over-year basis. Equities analysts predict that MetLife, Inc. will post 9.7 earnings per share for the current year.

MetLife Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 8th. Investors of record on Tuesday, August 4th will be issued a $0.5925 dividend. This represents a $2.37 annualized dividend and a yield of 2.4%. The ex-dividend date is Tuesday, August 4th. MetLife's dividend payout ratio is currently 45.40%.

MetLife announced that its Board of Directors has approved a stock repurchase plan on Wednesday, August 5th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to reacquire up to 4.8% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's board believes its stock is undervalued.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source